Cite
Fortuny J, von Gersdorff G, Lassalle R, et al. Use of intravenous iron and risk of anaphylaxis: A multinational observational post-authorisation safety study in Europe. Pharmacoepidemiol Drug Saf. 2021;30(10):1447-1457doi: 10.1002/pds.5319.
Fortuny, J., von Gersdorff, G., Lassalle, R., Linder, M., Overbeek, J., Reinold, J., Toft, G., Timmer, A., Dress, J., Blin, P., Droz-Perroteau, C., Ehrenstein, V., Franzoni, C., Herings, R., Kollhorst, B., Moore, N., Odsbu, I., Perez-Gutthann, S., Schink, T., Rascher, K., Rasouliyan, L., Rothman, K. J., Saigi-Morgui, N., Schaller, M., Smits, E., Forstner, M., Bénichou, J., Bircher, A. J., Garbe, E., Rampton, D. S., & Gutierrez, L. (2021). Use of intravenous iron and risk of anaphylaxis: A multinational observational post-authorisation safety study in Europe. Pharmacoepidemiology and drug safety, 30(10), 1447-1457. https://doi.org/10.1002/pds.5319
Fortuny, Joan, et al. "Use of intravenous iron and risk of anaphylaxis: A multinational observational post-authorisation safety study in Europe." Pharmacoepidemiology and drug safety vol. 30,10 (2021): 1447-1457. doi: https://doi.org/10.1002/pds.5319
Fortuny J, von Gersdorff G, Lassalle R, Linder M, Overbeek J, Reinold J, Toft G, Timmer A, Dress J, Blin P, Droz-Perroteau C, Ehrenstein V, Franzoni C, Herings R, Kollhorst B, Moore N, Odsbu I, Perez-Gutthann S, Schink T, Rascher K, Rasouliyan L, Rothman KJ, Saigi-Morgui N, Schaller M, Smits E, Forstner M, Bénichou J, Bircher AJ, Garbe E, Rampton DS, Gutierrez L. Use of intravenous iron and risk of anaphylaxis: A multinational observational post-authorisation safety study in Europe. Pharmacoepidemiol Drug Saf. 2021 Oct;30(10):1447-1457. doi: 10.1002/pds.5319. Epub 2021 Jul 12. PMID: 34181291; PMCID: PMC8457074.
Copy
Download .nbib